Original Research

What pricing and reimbursement policies to use for off-patent biologicals? – Results from the second EBE biological medicines policy survey

Author(s): , ,

Abstract: Objective: Biosimilar policies with a focus on uptake have received a lot of attention at national and regional level in the last few years. It is now 10 years… Read More »

Page 4 of 4 « Previous1 2 3 4
Go Back Print